What Is the Optimal Dose of Estradiol for Women in Menopause? | Felice Gersh, MD
Why It Matters
Ensuring menopausal patients achieve the 100 pg/mL estradiol target improves bone health and reduces fracture risk, directly impacting healthcare costs and quality of life.
Key Takeaways
- •Estradiol skin patches deliver variable blood levels across doses.
- •Only the 0.1 mg patch consistently reaches ~100 pg/mL in women.
- •100 pg/mL estradiol is threshold for optimal bone growth.
- •Lower-dose patches often fail to achieve therapeutic hormone levels.
- •Patch technology required patents due to skin’s poor hormone permeability.
Summary
The video examines how to determine the optimal estradiol dose for menopausal women using transdermal patches, emphasizing that the therapeutic goal is a target blood concentration rather than a fixed milligram amount.
Reviewing the original FDA‑approved studies, Dr. Gersh notes that blood levels varied widely across formulations, but only the 0.1 mg patch consistently produced estradiol concentrations around 100 pg/mL—a level shown to maximize bone mineral density gains.
She highlights that the skin was never designed for hormone delivery, which is why manufacturers patented specialized delivery matrices. Early trial data demonstrated that lower‑dose patches rarely reached the 100 pg/mL threshold, limiting their efficacy.
The implication for clinicians is clear: prescribing the highest‑strength patch and verifying serum estradiol can ensure bone‑protective benefits, while avoiding under‑dosing that may leave patients vulnerable to osteoporosis.
Comments
Want to join the conversation?
Loading comments...